Nuvonis is a biotech company based in Vienna, Austria, providing innovative and ready-to use GMP cell banks and technical support for vaccine process development
The Nuvonis team is highly experienced in cell line and process optimization for vaccine production
The fully characterized GMP Vero cells are cultivated without animal derived components and are non-tumorigenic beyond the end of production passage. This cell bank can be licensed for viral vaccine and vector manufacturing
A proprietary avian suspension cell line CCX.E10 (non-GMO) from primary quail cells was generated and can be licensed for viral vaccine and vector manufacturing.
All cell banks are available as GMP, fully characterized according to ICH guidelines